Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Performance Compounds Inside has developed 3PRE Technology, a proprietary method to activate molybdenum (and potentially other elements) to confer antimicrobial properties directly into metals and polymers during manufacturing. Lab results show rapid and significant kill rates against bacteria and viruses, including >98.7% reduction of human coronavirus 229E on activated molybdenum surfaces within one hour[7]. The technology is not a coating but is integrated into the material, offering durable antimicrobial protection. Applications span medical devices, orthopedics, equipment, and consumer products where infection control is critical[1][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Performance Compounds Inside.